LobbyingMountainstar Capital lobbying by quarter
Mountainstar Capital's latest lobbying report covers Q2 2026, at $30K. The four quarters Q3 2025–Q2 2026 total $120K. Its first report covers Q2 2025; the issues it reports most are Health Issues.
Mountainstar Capital
- Latest quarter
- $30K
- Q2 2026 · 1 reports
- Last 12 months
- $120K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $20K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
Policy issues the reports name
- Health issues2 reports
A report that names several issues counts once for each.
Who was lobbied
- Natl Institutes of Health (NIH)2 reports
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| TSG Advocates DC | $140K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | TSG Advocates DC | $30K |
| 04/20for Q1 | TSG Advocates DC | $30K |
| 01/15for Q4 2025 | TSG Advocates DC | $30K |
| 25/10/15for Q3 2025 | TSG Advocates DC | $30K |
| 25/07/10for Q2 2025 | TSG Advocates DC | $20K |
| 25/04/24for Q2 2025 | TSG Advocates DC | Under $5,000 |